PTCT insider trading
Open-market stock trades by PTC Therapeutics (PTCT) executives and directors: who bought or sold, how many shares, at what price and when.
PTCT insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 14, 2026 | SCHMERTZLER MICHAEL | director | Sell | 2,118 | $59.52 | $126.06K |
| Oct 14, 2026 | SCHMERTZLER MICHAEL | director | Sell | 382 | $60.14 | $22.97K |
| Oct 9, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 192 | $64.26 | $12.34K |
| Oct 7, 2026 | SCHMERTZLER MICHAEL | director | Sell | 2,447 | $63.38 | $155.09K |
| Oct 7, 2026 | SCHMERTZLER MICHAEL | director | Sell | 53 | $63.95 | $3.39K |
| Oct 5, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 1,638 | $64.03 | $104.88K |
| Oct 6, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 435 | $64.16 | $27.91K |
| Sep 30, 2026 | STEELE GLENN JR MD PHD | director | Sell | 12,000 | $65.16 | $781.92K |
| Sep 16, 2026 | SCHMERTZLER MICHAEL | director | Sell | 2,994 | $66.58 | $199.34K |
| Sep 16, 2026 | SCHMERTZLER MICHAEL | director | Sell | 7,006 | $67.35 | $471.85K |
| Sep 17, 2026 | SCHMERTZLER MICHAEL | director | Sell | 9,624 | $67.83 | $652.80K |
| Sep 17, 2026 | SCHMERTZLER MICHAEL | director | Sell | 376 | $68.45 | $25.74K |
| Sep 9, 2026 | SCHMERTZLER MICHAEL | director | Sell | 9,428 | $67.79 | $639.12K |
| Sep 9, 2026 | SCHMERTZLER MICHAEL | director | Sell | 572 | $68.67 | $39.28K |
| Sep 10, 2026 | SCHMERTZLER MICHAEL | director | Sell | 10,000 | $67.34 | $673.40K |
| Aug 26, 2026 | SCHMERTZLER MICHAEL | director | Sell | 6,874 | $72.74 | $500.01K |
| Aug 26, 2026 | SCHMERTZLER MICHAEL | director | Sell | 5,626 | $73.18 | $411.71K |
| Aug 27, 2026 | SCHMERTZLER MICHAEL | director | Sell | 11,890 | $71.55 | $850.73K |
| Aug 27, 2026 | SCHMERTZLER MICHAEL | director | Sell | 610 | $72.22 | $44.05K |
| Aug 19, 2026 | SCHMERTZLER MICHAEL | director | Sell | 5,335 | $72.86 | $388.71K |
| Aug 19, 2026 | SCHMERTZLER MICHAEL | director | Sell | 7,165 | $73.67 | $527.85K |
| Aug 20, 2026 | SCHMERTZLER MICHAEL | director | Sell | 9,419 | $70.78 | $666.68K |
| Aug 20, 2026 | SCHMERTZLER MICHAEL | director | Sell | 2,390 | $71.88 | $171.79K |
| Aug 20, 2026 | SCHMERTZLER MICHAEL | director | Sell | 691 | $72.92 | $50.39K |
| Aug 17, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 1,844 | $72.39 | $133.49K |
| Aug 17, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 969 | $72.90 | $70.64K |
| Aug 4, 2026 | Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 10,292 | $68.57 | $705.72K |
| Jul 14, 2026 | Gravier Pierre | CHIEF FINANCIAL OFFICER | Sell | 3,494 | $80.35 | $280.74K |
| Jul 9, 2026 | Smith Mary L. | director | Sell | 5,834 | $90.00 | $525.06K |
| Jul 9, 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Sell | 2,464 | $90.25 | $222.38K |
| Jul 6, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 387 | $83.10 | $32.16K |
| Jul 6, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 313 | $83.10 | $26.01K |
| Jul 6, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 1,036 | $84.41 | $87.45K |
| Jul 6, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 833 | $84.41 | $70.31K |
| Jul 6, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 645 | $85.84 | $55.37K |
| Jul 6, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 519 | $85.84 | $44.55K |
| Jul 6, 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 745 | $86.38 | $64.35K |
| Jul 7, 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Sell | 3,956 | $87.17 | $344.84K |
| Jul 6, 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Sell | 8,786 | $85.35 | $749.89K |
| Jul 7, 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Sell | 11,369 | $89.03 | $1.01M |
- PTCT insiders bought $0.00 and sold $11.97M in open-market trades over their last 40 filings.
Updated 2026-11-03 00:03 UTC